Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S. Dellon, Arsalan Shabbir, Marc E. Rothenberg et al.|New England Journal of Medicine|2022Cited by 452
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Jennifer Maloney, Evan S. Dellon et al.|New England Journal of Medicine|2024Cited by 107
Influence of the early-life gut microbiota on the immune responses to an inhaled allergenTimothy C. Borbet, Martin J. Blaser, Christian Taube et al.|Mucosal Immunology|2022Cited by 40
Mo1228 DUPILUMAB NORMALIZES THE EOSINOPHILIC ESOPHAGITIS DISEASE TRANSCRIPTOME IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITISJennifer D. Hamilton, Allen Radin, Wei Keat Lim et al.|Gastroenterology|2020Cited by 7
Dupilumab Normalized The Expression Of Genes Dysregulated In Eosinophilic Esophagitis (EoE) In Esophageal Biopsies From A Clinical Trial Of Children Aged 1–11 YearsMarc E. Rothenberg, Jennifer D. Hamilton, Wei Keat Lim et al.|Journal of Allergy and Clinical Immunology|2024Cited by 1